Enlarge-Lung: Two-Year Follow-Up of Real-World Patients with Locally Advanced or Metastatic (Stage IIIB/IV) Squamous and Non-Squamous Non-Small Cell Lung Cancer (NSCLC) from a National, Prospective, Non-Interventional Study (NiS Enlarge) of Nivolumab after Prior Chemotherapy in Germany

被引：0

作者：

Groeschell, Andreas ^{[1
]}

Schumann, Christian ^{[2
]}

Guetz, Sylvia ^{[3
]}

Schulz, Holger ^{[4
]}

Mueller-Huesmann, Harald ^{[5
]}

Schulte, Clemens ^{[6
]}

Liersch, Ruediger ^{[7
]}

von der Heyde, Eyck ^{[8
]}

Wuensch, Verena ^{[9
]}

Sebastian, Martin ^{[10
]}

机构：

[1] Clemenshospital, Klin Innere Med Pneumol & Beatmungsmed 2, Munster, Germany

[2] Klinikum Kempten, Pneumol Thoraxonkol Schlaf & Beatmungsmed, Kempten, Germany

[3] Ev Diakonissenkrankenhaus GmbH, Zentrum Innere Med, Leipzig, Germany

[4] Pioh, Frechen, Germany

[5] Bruderkrankenhaus St Josef, Klin Hamatol & Onkol, Paderborn, Germany

[6] Gemeinschaftspraxis Hamatol & Onkol, Dortmund, Germany

[7] GEHO, Gemeinschaftspraxis Hamatol & Onkol, Munster, Germany

[8] Studienzentrum Baschpl, Hannover, Germany

[9] Bristol Myers Squibb GmbH & Co KG aA, Munich, Germany

[10] Univ Klinikum Frankfurt, Med Klin 2, Hamatol Abt, Med Onkol, Frankfurt, Germany

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2020年 / 43卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

472

引用

页码：117 / 118

页数：2

共 50 条

[1] ENLARGE-Lung: Two-Year Follow-up of Real-World Patients with Locally Advanced or Metastatic (Stage IIIB/IV) Squamous and Non-Squamous Non-Small Cell Lung Cancer (NSCLC) from a National, Prospective, Non-Interventional Study (NIS ENLARGE) of Nivolumab after Prior Chemotherapy in Germany
Guetz, S.
Schumann, C.
Groeschel, M.
Schulte, C.
Schulz, H.
Mueller-Huesmann, H.
Liersch, R.
von der Heyde, E.
Wuensch, V
Sebastian, M.
[J]. PNEUMOLOGIE, 2020, 74 : S38 - S38
[2] ENLARGE-Lung: A national, prospective, Non-Interventional Study (NIS) of Nivolumab (Nivo) in patients (Pts) with locally advanced or metastatic Non-Small Cell Lung Cancer (NSCLC) with squamous and non-squamous histology (Stage IIIB/IV) after prior chemotherapy
Sebastian, M.
Groeschel, A.
Guetz, S.
Schumann, C.
[J]. ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 295 - 295
[3] ENLARGE-Lung: A National, Prospective, Non-Interventional Study (NIS) of Nivolumab (Nivo) in Patients (pts) with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) with Squamous and Non-Squamous Histology (Stage IIIB/IV) after Prior Chemotherapy
Schulz, H.
Sebastian, M.
Groeschel, A.
Guetz, S.
Schuette, W.
Mueller-Huesmann, H.
von der Heyde, E.
Schumann, C.
[J]. ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 109 - 109
[4] ENLARGE - Lung: a national, prospective, non-interventional study (NIS) of nivolumab (BMS-936558) in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with squamous and non-squamous histology (stage IIIB/IV) after prior chemotherapy
Sebastian, M.
Groeschel, A.
Guetz, S.
Schumann, C.
[J]. ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 249 - +
[5] Real-world evidence: interim analysis of efficacy in 628 patients with stage IIIB/IV non-small cell lung cancer (NSCLC) treated with Nivolumab after prior chemotherapy in a national, prospective, non-Interventional study (ENLARGE-Lung)
Sebastian, M.
Groeschel, A.
Guetz, S.
Schulz, H.
Mueller-Huesmann, H.
Schulte, C.
Wuensch, V.
Schumann, C.
[J]. ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 133 - 133
[6] Prospective, Noninterventional Study of Nivolumab in Real-world Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Chemotherapy (ENLARGE-Lung)
Sebastian, Martin
Groeschel, Andreas
Guetz, Sylvia
Schulz, Holger
Mueller-Huesmann, Harald
Liersch, Rudiger
von der Heyde, Eyck
Wiegand, Joerg
Ukena, Dieter
Bargon, Joachim
Schuette, Wolfgang
Riera-Knorrenschild, Jorge
Fischer, Juergen R.
Griesinger, Frank
Allan, Victoria
Waldenberger, Daniela
Schumann, Christian
[J]. JOURNAL OF IMMUNOTHERAPY, 2022, 45 (02) : 89 - 99
[7] ENLARGE Lung: Observational data on overall survival, safety and quality of life of 882 patients with locally advanced or metastatic (stage IIIB/IV) non-small cell lung cancer (NSCLC) treated with nivolumab in Germany
Schumann, C.
Groeschel, A.
Guetz, S.
Schulz, H.
Mueller-Huesmann, H.
Liersch, R.
von der Heyde, E.
Waldenberger, D.
Sebastian, M.
[J]. ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 150 - 150
[8] REAL-WORLD TREATMENT PATTERNS IN STAGE IV NON-SQUAMOUS NON-SMALL CELL LUNG CANCER IN ARGENTINA
Novick, D.
Hong, J.
Sheffield, K. M.
Mills, B. J.
Gallino, J.
[J]. VALUE IN HEALTH, 2017, 20 (09) : A881 - A881
[9] Economic Evaluation of Nivolumab Versus Docetaxel for the Treatment of Advanced Squamous and Non-squamous Non-small Cell Lung Cancer After Prior Chemotherapy in China
Hu, Shanlian
Tang, Zhiliu
Harrison, James P.
Hertel, Nadine
Penrod, John R.
May, Jessica R.
Juarez-Garcia, Ariadna
Holdgate, Orban
[J]. PHARMACOECONOMICS-OPEN, 2023, 7 (02) : 273 - 284
[10] Economic Evaluation of Nivolumab Versus Docetaxel for the Treatment of Advanced Squamous and Non-squamous Non-small Cell Lung Cancer After Prior Chemotherapy in China
Shanlian Hu
Zhiliu Tang
James P. Harrison
Nadine Hertel
John R. Penrod
Jessica R. May
Ariadna Juarez-Garcia
Orban Holdgate
[J]. PharmacoEconomics - Open, 2023, 7 : 273 - 284

← 1 2 3 4 5 →